Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation.

[1]  A. Penna,et al.  Pharmacological Characterization and Molecular Determinants of the Activation of Transient Receptor Potential V2 Channel Orthologs by 2-Aminoethoxydiphenyl Borate , 2007, Molecular Pharmacology.

[2]  A. Pébay,et al.  Stem cell regulation by lysophospholipids. , 2007, Prostaglandins & other lipid mediators.

[3]  S. Hwang,et al.  Transient receptor potential V2 expressed in sensory neurons is activated by probenecid , 2007, Neuroscience Letters.

[4]  M. E. Buck,et al.  Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. , 2007, Biochemical and biophysical research communications.

[5]  Feng Hao,et al.  Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. , 2007, Biochimica et biophysica acta.

[6]  M. Roudbaraki,et al.  Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. , 2007, The Journal of clinical investigation.

[7]  T. Hutchinson,et al.  Activation Properties of Heterologously Expressed Mammalian TRPV2 , 2007, Journal of Biological Chemistry.

[8]  Sun Young Lee,et al.  S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. , 2007, Biochemical and biophysical research communications.

[9]  D. Luo,et al.  Involvement of endothelial cell-derived CGRP in heat stress-induced protection of endothelial function. , 2007, Vascular pharmacology.

[10]  D. Andersson,et al.  Modulation of the Cold-Activated Channel TRPM8 by Lysophospholipids and Polyunsaturated Fatty Acids , 2007, The Journal of Neuroscience.

[11]  I. Kojima,et al.  Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages , 2007, Journal of cellular physiology.

[12]  Stephen P. H. Alexander,et al.  Guide to Receptors and Channels, 2nd edition (2007 Revision) , 2007 .

[13]  D. Geraghty,et al.  Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. , 2007, Molecular immunology.

[14]  V. Flockerzi.  An introduction on TRP channels. , 2007, Handbook of experimental pharmacology.

[15]  Y. Panchin,et al.  Ca2+-independent Phospholipase A2-dependent Gating of TRPM8 by Lysophospholipids* , 2006, Journal of Biological Chemistry.

[16]  P. Houillier,et al.  Tissue kallikrein stimulates Ca2+ reabsorption via PKC‐dependent plasma membrane accumulation of TRPV5 , 2006, The EMBO journal.

[17]  A. Penna,et al.  PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane. , 2006, Cell calcium.

[18]  P. Delcourt,et al.  Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells. , 2006, Endocrine-related cancer.

[19]  David J Beech,et al.  Sensing of Lysophospholipids by TRPC5 Calcium Channel* , 2006, Journal of Biological Chemistry.

[20]  J A Peters,et al.  Guide to Receptors and Channels, 1st Edition , 2004, British journal of pharmacology.

[21]  Y. Panchin,et al.  Novel Role of Cold/Menthol-sensitive Transient Receptor Potential Melastatine Family Member 8 (TRPM8) in the Activation of Store-operated Channels in LNCaP Human Prostate Cancer Epithelial Cells* , 2005, Journal of Biological Chemistry.

[22]  S. W. Lee,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells , 2005, International Journal of Impotence Research.

[23]  V. Kamanna,et al.  Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. , 2005, Histology and histopathology.

[24]  Alexander J Stokes,et al.  Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2 , 2005, Journal of cellular biochemistry.

[25]  G. Raj,et al.  Lysophosphatidic acid promotes survival of androgen‐insensitive prostate cancer PC3 cells via activation of NF‐κB , 2004, The Prostate.

[26]  M. Zhu,et al.  2-Aminoethoxydiphenyl Borate Is a Common Activator of TRPV1, TRPV2, and TRPV3* , 2004, Journal of Biological Chemistry.

[27]  J. Chun,et al.  Lysophospholipid receptors: signaling and biology. , 2004, Annual review of biochemistry.

[28]  J. Chun,et al.  Lysophospholipid G Protein-coupled Receptors* , 2004, Journal of Biological Chemistry.

[29]  G. Fernández-Ballester,et al.  Molecular architecture of the vanilloid receptor. Insights for drug design. , 2004, European journal of biochemistry.

[30]  H. Suh,et al.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Medicine.

[31]  Xuemin Wang.  Lipid signaling. , 2004, Current opinion in plant biology.

[32]  Stanley L. Hazen,et al.  Identification of &agr;-Chloro Fatty Aldehydes and Unsaturated Lysophosphatidylcholine Molecular Species in Human Atherosclerotic Lesions , 2003 .

[33]  KatsuhikoMuraki,et al.  TRPV2 Is a Component of Osmotically Sensitive Cation Channels in Murine Aortic Myocytes , 2003 .

[34]  M. Berridge,et al.  Calcium: Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature Reviews Molecular Cell Biology.

[35]  Yuji Arai,et al.  A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor–regulated channel , 2003, The Journal of cell biology.

[36]  Marie-Luise Brennan,et al.  Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. , 2003, Circulation.

[37]  I. Hwang,et al.  Phosphatidylinositol 3- and 4-Phosphate Are Required for Normal Stomatal Movements Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.004143. , 2002, The Plant Cell Online.

[38]  I. Kojima,et al.  Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. , 2002, Endocrine journal.

[39]  A. Randall,et al.  Vanilloid and TRP channels: a family of lipid-gated cation channels , 2002, Neuropharmacology.

[40]  Y. Daaka.  Mitogenic action of LPA in prostate. , 2002, Biochimica et biophysica acta.

[41]  A. Tokumura.  Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. , 2002, Biochimica et biophysica acta.

[42]  P. Albert,et al.  G protein specificity: traffic direction required. , 2002, Cellular signalling.

[43]  P. Chieffi,et al.  Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells , 2002, Molecular and Cellular Endocrinology.

[44]  H. Schaller,et al.  The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC. , 2001, Journal of cell science.

[45]  S. Kawashima,et al.  Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. , 2000, Journal of atherosclerosis and thrombosis.

[46]  M. Kanzaki,et al.  Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I , 1999, Nature Cell Biology.

[47]  D. Julius,et al.  A capsaicin-receptor homologue with a high threshold for noxious heat , 1999, Nature.

[48]  D. Linseman,et al.  A role for a wortmannin-sensitive phosphatidylinositol-4-kinase in the endocytosis of muscarinic cholinergic receptors. , 1998, Molecular pharmacology.

[49]  G. Mills,et al.  Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.

[50]  G. Mills,et al.  Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.